Security key
12674W109
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA)
CUSIP: 12674W109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 116,279,070
- Total 13F shares
- 50,801,335
- Share change
- -236,419
- Total reported value
- $379,995,301
- Put/Call ratio
- 220%
- Price per share
- $7.48
- Number of holders
- 137
- Value change
- -$32,124,100
- Number of buys
- 70
- Number of sells
- 83
Report period
Q2 2024
Institutions
137
Top holders
10
CABA full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Cabaletta Bio, Inc. SEC filings
Cabaletta Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 12674W109
Recent filing periods:
Top shareholders of CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
3.5%
|
4,057,113
|
$69,214,348 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
3,741,460
|
$63,829,308 | — | 31 Mar 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.9%
|
3,422,984
|
$58,396,108 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
2.7%
|
3,110,314
|
$53,061,957 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.6%
|
3,036,645
|
$51,805,164 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.1%
|
2,470,493
|
$42,147,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
2,276,222
|
$38,832,347 | — | 31 Mar 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
1.8%
|
2,082,973
|
$35,535,519 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
1,716,660
|
$29,286,220 | — | 31 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.4%
|
1,617,364
|
$27,592,230 | — | 31 Mar 2024 | |
| Venrock Adviser, LLC |
13F
|
Company |
1.3%
|
1,563,952
|
$26,681,021 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.1%
|
1,258,650
|
$21,472,569 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.1%
|
1,250,000
|
$21,325,000 | — | 31 Mar 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.95%
|
1,100,000
|
$18,766,000 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.95%
|
1,100,000
|
$18,766,000 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.87%
|
1,008,259
|
$17,200,899 | — | 31 Mar 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.86%
|
1,003,916
|
$17,126,807 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.76%
|
885,704
|
$15,110,110 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
773,090
|
$13,190,766 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.64%
|
744,777
|
$12,705,896 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.53%
|
612,398
|
$10,448,000 | — | 31 Mar 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.43%
|
500,000
|
$8,530,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
459,367
|
$7,836,801 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
0.38%
|
442,826
|
$7,554,612 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.37%
|
434,500
|
$7,412,570 | — | 31 Mar 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.37%
|
429,746
|
$7,331,467 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
425,174
|
$7,253,469 | — | 31 Mar 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.37%
|
425,000
|
$7,250,500 | — | 31 Mar 2024 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.36%
|
417,000
|
$7,114,000 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.32%
|
375,000
|
$6,397,500 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.32%
|
371,623
|
$6,339,888 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.3%
|
354,424
|
$6,046,473 | — | 31 Mar 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.29%
|
334,813
|
$5,711,910 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.28%
|
330,925
|
$5,645,580 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.27%
|
317,520
|
$5,416,890 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
304,161
|
$5,188,987 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.26%
|
301,886
|
$5,150,175 | — | 31 Mar 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.25%
|
290,797
|
$4,960,997 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.24%
|
282,651
|
$4,822,026 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
278,123
|
$4,744,778 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.21%
|
242,663
|
$4,139,831 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
238,103
|
$4,062,037 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.18%
|
209,476
|
$3,573,661 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.17%
|
200,000
|
$3,412,000 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
198,037
|
$3,378,512 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
0.15%
|
178,162
|
$3,039,444 | — | 31 Mar 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.15%
|
173,173
|
$2,954,331 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.15%
|
171,187
|
$2,920,450 | — | 31 Mar 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.14%
|
164,605
|
$2,808,162 | — | 31 Mar 2024 | |
| Caption Management, LLC |
13F
|
Company |
0.14%
|
160,000
|
$2,729,600 | — | 31 Mar 2024 |
Institutional Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2024
As of 30 Jun 2024,
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,801,335 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, BlackRock Inc., T. Rowe Price Investment Management, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., ALKEON CAPITAL MANAGEMENT LLC, FRED ALGER MANAGEMENT, LLC, VANGUARD GROUP INC, STATE STREET CORP, Bain Capital Life Sciences Investors, LLC, and VR Adviser, LLC.
This page lists
137
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
157
Q2 2024 holders
137
Holder diff
-20
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.